Blog
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics
Tempus AI TEM continues to expand its leadership in precision medicine through a series of impactful research initiatives and clinical validations. Throughout 2025 and early 2026, the company
CareCloud, Inc. (CCLD) Q4 Earnings Match Estimates
CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago. These figures are
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
ProQR (PRQR) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.1 per share a year ago. These figures are
XPeng to Launch VLA 2.0 Autonomous Driving Platform in 2027
XPeng Inc. XPEV announced that its second-generation Vision-Language-Action autonomous driving system, VLA 2.0, is scheduled for global deployment starting in 2027, marking an important development
Can Operational Efficiency Sustain Shake Shack's EBITDA Momentum?
Shake Shack Inc.’s SHAK recent performance highlights how operational efficiency is becoming a key driver of its profitability and EBITDA growth. In 2025, the company reported revenue growth of
SNDK Rides on Strong NAND Demand: How AI Push is Lifting Prospect
Sandisk SNDK is benefiting from a shift in NAND flash demand tied to artificial intelligence (AI) infrastructure buildouts. The result is a more constructive supply-demand balance and a better
US CPI Up 0.3% in February: Consumer Discretionary ETFs to Watch
U.S. consumer prices rose moderately in February, with the Consumer Price Index (CPI) rising 0.3% for the month, according to data released by the U.S. Labor Department. The reading, which left the
Nuclear ETFs in Spotlight as Middle East Conflict Intensifies Energy Crisis
The escalating U.S.–Israel conflict with Iran has plunged global energy markets into turmoil, with the Strait of Hormuz — through which about 20% of the world’s crude oil passes — now effectively a
Viasat Expands NexusWave Deployment Across EXMAR's Gas Carrier Fleet
Viasat, Inc. VSAT, through its Inmarsat Maritime unit, is deploying the NexusWave connectivity service across the expanding fleet of gas carriers operated by EXMAR. The rollout aims to support
Campbell's Q2 Earnings & Revenues Miss Estimates, Sales Down 5% Y/Y
The Campbell's Company CPB reported second-quarter fiscal 2026 results, with the top and bottom lines missing the Zacks Consensus Estimate. Both net sales and earnings experienced year-over-year
Walmart eCommerce Up 24%: Can Digital Momentum Continue?
Walmart Inc.’s WMT fourth-quarter fiscal 2026 results highlighted a strong 24% surge in global eCommerce sales, underscoring the retailer’s steady transition into a tech-powered omnichannel leader
Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on lower revenues when Monte Rosa Therapeutics (GLUE) reports results for the quarter ended December 2025. While this widely-known consensus
Scholastic (SCHL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Scholastic (SCHL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook gives
Analysts Estimate Arcos Dorados (ARCO) to Report a Decline in Earnings: What to Look Out for
Arcos Dorados (ARCO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook
Signet (SIG) Expected to Beat Earnings Estimates: Should You Buy?
Signet (SIG) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives a
FedEx (FDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects FedEx (FDX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is
Darden Restaurants (DRI) Earnings Expected to Grow: Should You Buy?
Darden Restaurants (DRI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus
Accenture (ACN) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Accenture (ACN) reports results for the quarter ended February 2026. While this widely-known consensus outlook is
Best Momentum Stocks to Buy for March 12th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 12:
ADMA Biologics, Inc. ADMA: This biopharmaceutical company has a Zacks Rank #1 and
Implied Volatility Surging for Kura Oncology Stock Options
Investors in Kura Oncology Inc. KURA need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $17.00 Call had some of the highest
Can Papa John's Digital Investments & Loyalty Expansion Drive Growth?
Papa John's PZZA is strengthening the digital ecosystem and loyalty platform as part of its ongoing transformation strategy. The company is focusing on improving the digital ordering experience and
Can Domino's Same-Store Sales Strength Support Retail Growth in 2026?
Domino's Pizza, Inc. DPZ relies on strong same-store sales to support overall retail growth across its global system. The company focuses on driving higher order volumes, strengthening store-level
Here's Why Maximus (MMS) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in Maximus (MMS) lately. While the stock has lost 5.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading
Health Catalyst (HCAT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for Health Catalyst (HCAT) has been bearish lately and the stock has lost 6.5% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session
GT Biopharma (GTBP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Shares of GT Biopharma, Inc. (GTBP) have been struggling lately and have lost 6.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean


